Pasar al contenido principal

NUEVAS DIANAS TERAPEUTICAS EN LA ENFERMEDAD CEREBROVASCULAR AGUDA Y CRONICA: EL RECEPTOR DE HIDROCARBUROS AROMATICOS (AHR)

SAF2015-68632-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance

  • Peña Martínez, Carolina Belén
  • Durán Laforet, Violeta
  • García Culebras, Alicia
  • Ostos, Fernando
  • Hernández Jiménez, Macarena
  • Bravo-Ferrer, Isabel
  • Pérez Ruiz, Alberto
  • Bellenilla, Federico
  • Díaz Guzmán, Jaime
  • Lizasoaín Hernández, Ignacio
  • Moro Sánchez, María Ángeles
Background and Purpose- Recanalization of the occluded artery is a primary goal in stroke treatment. Unfortunately, endovascular treatment is not always available, and tPA (tissue-type plasminogen activator) therapy is limited by its narrow therapeutic window; importantly, the rate of early arterial recanalization after tPA administration is low, especially for platelet-rich thrombi. The mechanisms for this tPA resistance are not well known. Since neutrophil extracellular traps (NETs) have been implicated in this setting, our aim was to study whether NET pharmacological modulation can reverse tPA resistance and the role of TLR4 (Toll-like receptor 4), previously related to NET formation, in thrombosis. Methods- To this goal, we have used a mouse photothrombotic stroke model, which produces a fibrin-free thrombus composed primarily of aggregated platelets and thrombi obtained from human stroke patients. Results- Our results demonstrate that (1) administration of DNase-I, which promotes NETs lysis, but not of tPA, recanalizes the occluded vessel improving photothrombotic stroke outcome; (2) a preventive treatment with Cl-amidine, impeding NET formation, completely precludes thrombotic occlusion; (3) platelet TLR4 mediates NET formation after photothrombotic stroke; and (4) ex vivo fresh platelet-rich thrombi from ischemic stroke patients are effectively lysed by DNase-I. Conclusions- Hence, our data open new avenues for recanalization of platelet-rich thrombi after stroke, especially to overcome tPA resistance.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Role of TLR4 (toll-like receptor 4) in N1/N2 neutrophil programming after stroke

  • García-Culebras, Alicia
  • Durán-Laforet, Violeta
  • Peña-Martínez, Carolina
  • Moraga, Ana
  • Ballesteros, Iván
  • Cuartero, María Isabel
  • de la Parra, Juan
  • Palma-Tortosa, Sara
  • Hidalgo, Andrés
  • Corbí, Angel L.
  • Moro, María A.
  • Lizasoain, Ignacio
11p.-5 fig., Background and Purpose—After stroke, the population of infiltrated neutrophils in the brain is heterogeneous, including a population of alternative neutrophils (N2) that express M2 phenotype markers. We explored the role of TLR4 (toll-likereceptor 4) on neutrophil infiltration and polarization in this setting., Methods—Focal cerebral ischemia was induced by occlusion of the middle cerebral artery occlusion in TLR4-KO and WT (wild type) mice. Infarct size was measured by Nissl staining and magnetic resonance imaging. Leukocyte infiltration was quantified 48 hours after middle cerebral artery occlusion by immunofluorescence and flow cytometry. To elucidate mechanisms underlying TLR4-mediated N2 phenotype, a cDNA microarray analysis was performed in neutrophils isolated from blood 48 hours after stroke in WT and TLR4-KO mice., Results—As demonstrated previously, TLR4-deficient mice presented lesser infarct volumes than WT mice. TLR4-deficient mice showed higher density of infiltrated neutrophils 48 hours after stroke compared with WT mice, concomitantly to neuroprotection. Furthermore, cytometric and stereological analyses revealed an increased number of N2 neutrophils(YM1+ cells) into the ischemic core in TLR4-deficient mice, suggesting a protective effect of this neutrophil subset that was corroborated by depleting peripheral neutrophils or using mice with TLR4 genetically ablated in the myeloid lineage.Finally, cDNA microarray analysis in neutrophils, confirmed by quantitative polymerase chain reaction, showed that TLR4 modulates several pathways associated with ischemia-induced inflammation, migration of neutrophils into the parenchyma,and their functional priming, which might explain the opposite effect on outcome of the different neutrophil subsets., Conclusions—TLR4 deficiency increased the levels of alternative neutrophils (N2)—an effect associated with neuroprotection after stroke—supporting that modulation of neutrophil polarization is a major target of TLR4 and highlighting the crucial role of TLR4 at the peripheral level after stroke., This work was supported by grants from Instituto de Salud Carlos III and cofinanced by the European Development Regional Fund “A way to achieve Europe” (PI17/01601 and RETICS RD16/0019/0009;Dr Lizasoain), from Regional Madrid Government B2017/BMD-3688 (Dr Lizasoain) and from Spanish Ministry of Economy and Competitiveness SAF2015-68632-R (Dr Moro)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lack of the aryl hydrocarbon receptor accelerates aging in mice

  • Bravo-Ferrer, Isabel
  • Cuartero, María Isabel
  • Medina, Violeta
  • Ahedo-Quero, Dalia
  • Peña-Martínez, Carolina
  • Pérez-Ruíz, Alberto
  • Fernández-Valle, Encarnación
  • Hernández-Sánchez, Catalina
  • Fernández-Salguero, Pedro M.
  • Lizasoain, Ignacio
  • Moro, María A.
11p.-5 fig.-1 tab., The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor, largely known for its role in xenobiotic metabolism and detoxification as well as its crucial role as a regulator of inflammation. Here, we have compared a cohort wild-type and AhR-null mice along aging to study the relationship between this receptor and age-associated inflammation, termed as "inflammaging," both at a systemic and the CNS level. Our results show that AhR deficiency is associated with a premature aged phenotype, characterized by early inflammaging, as shown by an increase in plasma cytokines levels. The absence of AhR also promotes the appearance of brain aging anatomic features, such as the loss of the white matter integrity. In addition, AhR-/- mice present an earlier spatial memory impairment and an enhanced astrogliosis in the hippocampus when compared with their age-matched AhR+/+ controls. Importantly, we have found that AhR protein levels decrease with age in this brain structure, strongly suggesting a link between AhR and aging.-Bravo-Ferrer, I., Cuartero, M. I., Medina, V., Ahedo-Quero, D., Peña-Martínez, C., Pérez-Ruíz, A., Fernández-Valle, M. E., Hernández-Sánchez, C., Fernández-Salguero, P. M., Lizasoain, I., Moro, M. A. Lack of the aryl hydrocarbon receptor accelerates aging in mice., This work was supported by the Spanish Ministry of Economy and Competitiveness (Grants SAF2015-68632-R and SAF2016-81716-REDC to M.A.M.), Instituto de Salud Carlos III,cofinanced by Fondo Europeo de Desarrollo Regional (FEDER) Una Manera de Hacer Europa (Grants PI17/01601 and RD16/0019/0009 to I.L.), and the Regional Madrid Government (Grant B2017/BMD-3688 to I.L.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Neutrophil Timer Coordinates Immune Defense and Vascular Protection

  • Adrover, José M.
  • Fresno, Carlos del
  • Crainiciuc, Georgiana
  • Cuartero, María Isabel
  • Casanova-Acebes, María
  • Weiss, Linnea A.
  • Huerga Encabo, Héctor
  • Silvestre-Roig, C.
  • Rossaint, Jan
  • Cossío, Itziar
  • Lechuga-Vieco, Ana V.
  • García-Prieto, Jaime
  • Gómez-Parrizas, Mónica
  • Quintana, Juan A.
  • Ballesteros, Iván
  • Martin-Salamanca, Sandra
  • Aroca-Crevillen, Alejandra
  • Zhen Chong, Shu
  • Evrard, Maximilien
  • Balabanian, Karl
  • López, Jorge
  • Bidzhekov, Kiril
  • Bachelerie, Françoise
  • Abad-Santos, Francisco
  • Muñoz-Calleja, Cecilia
  • Zarbock, Alexander
  • Soehnlein, Oliver
  • Weber, C.
  • Guan Ng, Lai
  • López-Rodríguez, Cristina
  • Sancho, David
  • Moro, María A.
  • Ibáñez, Borja
  • Hidalgo, Andrés
Neutrophils eliminate pathogens efficiently but can inflict severe damage to the host if they over-activate within blood vessels. It is unclear how immunity solves the dilemma of mounting an efficient anti-microbial defense while preserving vascular health. Here, we identify a neutrophil-intrinsic program that enabled both. The gene Bmal1 regulated expression of the chemokine CXCL2 to induce chemokine receptor CXCR2-dependent diurnal changes in the transcriptional and migratory properties of circulating neutrophils. These diurnal alterations, referred to as neutrophil aging, were antagonized by CXCR4 (C-X-C chemokine receptor type 4) and regulated the outer topology of neutrophils to favor homeostatic egress from blood vessels at night, resulting in boosted anti-microbial activity in tissues. Mice engineered for constitutive neutrophil aging became resistant to infection, but the persistence of intravascular aged neutrophils predisposed them to thrombo-inflammation and death. Thus, diurnal compartmentalization of neutrophils, driven by an internal timer, coordinates immune defense and vascular protection. Neutrophils display circadian oscillations in numbers and phenotype in the circulation. Adrover and colleagues now identify the molecular regulators of neutrophil aging and show that genetic disruption of this process has major consequences in immune cell trafficking, anti-microbial defense, and vascular health., This study was supported by Intramural grants from A∗STAR to L.G.N., BES-2013-065550 to J.M.A., BES-2010-032828 to M.C.-A, and JCI-2012-14147 to L.A.W (all from Ministerio de Economía, Industria y Competitividad; MEIC). Additional MEIC grants were SAF2014-61993-EXP to C.L.-R.; SAF2015-68632-R to M.A.M. and SAF-2013-42920R and SAF2016-79040Rto D.S. D.S. also received 635122-PROCROP H2020 from the European Commission and ERC CoG 725091 from the European Research Council (ERC). ERC AdG 692511 PROVASC from the ERC and SFB1123-A1 from the Deutsche Forschungsgemeinschaft were given to C.W.; MHA VD1.2/81Z1600212 from the German Center for Cardiovascular Research (DZHK) was given to C.W. and O.S.; SFB1123-A6 was given to O.S.; SFB914-B08 was given to O.S. and C.W.; and INST 211/604-2, ZA 428/12-1, and ZA 428/13-1 were given to A.Z. This study was also supported by PI12/00494 from Fondo de Investigaciones Sanitarias (FIS) to C.M.; PI13/01979, Cardiovascular Network grant RD 12/0042/0054, and CIBERCV to B.I.; SAF2015-65607-R, SAF2013-49662-EXP, and PCIN-2014-103 from MEIC; and co-funding by Fondo Europeo de Desarrollo Regional (FEDER) to A.H. The CNIC is supported by the MEIC and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (MEIC award SEV-2015-0505).
Docta Complutense
Publicación Artículo científico (JournalArticle)

Test repositioning for functional assessment of neurological outcome after experimental stroke in mice

  • Hernández Jiménez, Macarena
  • Peña Martínez, Carolina Belén
  • Godino, María del Carmen
  • Díaz Guzmán, Jaime
  • Moro Sánchez, María Ángeles
  • Lizasoaín Hernández, Ignacio
Stroke is a cerebrovascular pathology for which the only approved treatment is fibrinolysis. Several studies have focused on the development of new drugs but none has led to effective therapies to date, due, among others, to the difficulty to evaluate clinical deficits in experimental animal models. The present study aims to explore the applicability of known behavioral tests not commonly used in ischemia for the neurological assessment of mice after experimental stroke in different brain areas. A total of 225 CD1 male mice were randomly assigned to permanent middle cerebral artery occlusion by ligature (pMCAO) or permanent anterior cerebral artery occlusion by photothrombosis (pACAO) models. Modified neuroseverity score, footprint test, forced swim test and elevated plus maze were performed. Under these experimental conditions, modified neuroseverity score showed neurological impairment early after experimental stroke in both models. By contrast, the footprint test and the elevated plus maze detected short-term neurological deterioration in the pMCAO model but not in the pACAO model. Furthermore, the forced swim test identified depression-like behavior in mice after ischemia only when the left hemisphere was affected. In conclusion, we propose the repositioning of known neurobehavioral tests, but not commonly used in the stroke field, for the fast detection of neurological impairments early after ischemia, and even specific to discriminate the territory affected by arterial occlusion as well as the hemisphere where brain damage occurs. All these findings may prove useful to improve the experimental design of neuroprotective drugs in order to bridge the gap between experimental studies and clinical trials.